Home
HelpEPIC ORDER CODE LAB3200 MVista Histoplasma Ag Quantitative EIA
Additional Codes
SQ: FHST
Reporting Name
MVista Histoplasma AntigenPerforming Laboratory
MiraVista DiagnosticsSpecimen Type
VariesSpecimen Required
Specimen Type: Bronchial washing or body fluid
Container/Tube: Sterile, leak-proof screw cap container
Specimen Volume: 2 mL
Collection Instructions:
1. Collect 2 mL of bronchial washing or body fluid in a sterile, leak-proof screw cap container.
2. Label with specimen type (required).
3. Send refrigerate.
Note:
1. MiraVista will test most body fluids with the following disclaimer: The reference range and other method performance specifications have not been established for this test in this type of body fluid. The test results should be integrated into the clinical context for interpretation.
2. New York approved for Urine, Serum, Plasma, spinal fluid (CSF), and bronchoalveolar lavage (BAL) specimens.
Specimen Minimum Volume
Bronchial washing/Body fluid: 0.5 mL (Note: Minimum volume does not allow for repeats.)
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Refrigerated (preferred) | 14 days |
| Ambient | 14 days | |
| Frozen | ||
Reference Values
Reference interval: None Detected
Reportable Range: Positive Results reported in ng/mL from 0.20 ng/mL to 20.00 ng/mL
Positive Results above 20.00 ng/mL are reported as “Above the Limit of Quantification"
Day(s) Performed
Monday through Friday
CPT Code Information
87385
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| FHST | MVista Histoplasma Antigen | 57766-8 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| Z1746 | Specimen Type | 31208-2 |
| Z1747 | Result | 57766-8 |
| Z1748 | Interpretation | 59464-8 |
Report Available
3 to 5 daysReject Due To
| Specimen that is too viscous to pipette. | Reject |
| Tissue, biopsy, sputum, bronchial brush, tracheal aspirate, fine needle aspirate, bone marrow aspirate, stool or specimens | Reject |
| Specimens in transport media, fixative or Isolator tubes | Reject |
Test Classification
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.Method Name
Quantitative Sandwich Enzyme Immunoassay (EIA)
Clinical Information
Refer to https://miravistalabs.com/